Drugs / TPN171H
Trials 14 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 19 trials | ||||||
| Phase 1 | NCT05585931 | Nov → Dec 2022 | erectile dysfunction | Vigonvita Life Sciences | Completed | No outcome recorded |
| Phase 1 | NCT05750355 | Oct → Dec 2022 | — | Vigonvita Life Sciences | Completed | No outcome recorded |
| Phase 1 | NCT05208814 | Mar → Oct 2022 | erectile dysfunction, pulmonary arterial hypertension | Vigonvita Life Sciences | Completed | No outcome recorded |
| Phase 1 | NCT05316428 | Feb → Apr 2022 | alcohol-related disorders, erectile dysfunction | Vigonvita Life Sciences | Completed | No outcome recorded |
| Phase 1 | NCT05185011 | Dec 2021 → Feb 2022 | erectile dysfunction, pulmonary arterial hypertension | Vigonvita Life Sciences | Completed | No outcome recorded |
| Phase 1 | NCT04655872 | Nov 2020 → Jan 2021 | — | Vigonvita Life Sciences | Completed | No outcome recorded |
| Phase 1 | NCT06090136 | Sep → Dec 2020 | erectile dysfunction | Vigonvita Life Sciences | Completed | No outcome recorded |
| Phase 1 | NCT06090123 | Jan → Apr 2020 | erectile dysfunction | Vigonvita Life Sciences | Completed | No outcome recorded |
| Phase 1 | NCT05948644 | Apr 2019 → Oct 2020 | pulmonary arterial hypertension | Vigonvita Life Sciences | Completed | No outcome recorded |
| Phase 23 trials | ||||||
| Phase 2 | NCT05388825 | Aug 2022 → Jan 2023 | erectile dysfunction | Vigonvita Life Sciences | Completed | No outcome recorded |
| Phase 2 | NCT04483115 | Nov 2020 → Jun 2022 | pulmonary arterial hypertension | Vigonvita Life Sciences | Completed | No outcome recorded |
| Phase 2 | NCT04479917 | Jul 2020 → Jul 2021 | erectile dysfunction | Vigonvita Life Sciences | Completed | No outcome recorded |
| Phase 32 trials | ||||||
| Phase 3 | NCT06301854 | Apr 2024 → Jun 2025 | erectile dysfunction | Vigonvita Life Sciences | Completed | No outcome recorded |
| Phase 3 | NCT05188989 | Dec 2021 → Feb 2023 | erectile dysfunction | Vigonvita Life Sciences | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 16 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TPN171H | “Single dose of 10mg TPN171H on Day 1” NCT06090123 ↗ |
| Known as | TPN171 | “This study aimed to assess the immediate impact of a single dose of TPN171 (10 mg) on semen quality in healthy male Chinese volunteers.” PMID 40181588 ↗ Apr 2025 |
| Action | Inhibit | “TPN171 is a phosphodiesterase-5 inhibitor.” PMID 40277393 ↗ Apr 2025 |
| Route | Oral | “Route of administration:;oral” NCT04479917 ↗ |